Literature DB >> 8555890

Acyclovir in recurrent herpes labialis.

G Worrall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8555890      PMCID: PMC2349724          DOI: 10.1136/bmj.312.7022.6

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

1.  Topical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisal.

Authors:  G Worrall
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

2.  The natural history of recurrent facial-oral infection with herpes simplex virus.

Authors:  C Bader; C S Crumpacker; L E Schnipper; B Ransil; J E Clark; K Arndt; I M Freedberg
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

3.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

Review 4.  Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.

Authors:  S L Spruance
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

5.  Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.

Authors:  R C Reichman; G J Badger; G J Mertz; L Corey; D D Richman; J D Connor; D Redfield; M C Savoia; M N Oxman; Y Bryson
Journal:  JAMA       Date:  1984-04-27       Impact factor: 56.272

6.  An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins.

Authors:  T J Hill; W A Blyth
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

7.  The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir.

Authors:  S L Spruance; D J Freeman; J C Stewart; M B McKeough; L G Wenerstrom; G G Krueger; M W Piepkorn; W G Stroop; N H Rowe
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

8.  Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients.

Authors:  S E Straus; M Seidlin; H Takiff; D Jacobs; D Bowen; H A Smith
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

9.  Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.

Authors:  J F Rooney; S E Straus; M L Mannix; C R Wohlenberg; D W Alling; J A Dumois; A L Notkins
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391

  9 in total
  4 in total

1.  Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak.

Authors:  G Worrall
Journal:  BMJ       Date:  1996-07-06

2.  Topical acyclovir is beneficial in recurrent herpes labialis.

Authors:  P J Lamey
Journal:  BMJ       Date:  1996-04-13

Review 3.  Interventions for prevention of herpes simplex labialis (cold sores on the lips).

Authors:  Ching-Chi Chi; Shu-Hui Wang; Finola M Delamere; Fenella Wojnarowska; Mathilde C Peters; Preetha P Kanjirath
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07

4.  Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes.

Authors:  Hanan Polansky; Adrian Javaherian; Edan Itzkovitz
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.